![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
描述Idecabtagene Vicleucel的细胞扩张以及与三级暴露复发/反射性多发性髓瘤患者的临床有效性和安全性的关联
Fan Wu1, Xirong Zheng1, Joseph Burnett1
1Translational Medical and Clinical Pharmacology, Bristol Myers Squibb, Princeton, NJ, USA.
Journal of clinical pharmacology
|July 11, 2025
概括
细胞扩张idecabtagene vicleucel (ide-cel) 与多发性骨髓瘤的改善结果相关. 更高的理想细胞扩张与更长的无进展生存率和响应率有关,支持剂量范围的调整.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 药理动力学 药理动力学
背景情况:
- Idecabtagene vicleucel (ide-cel) 是一种用于治疗复发性/耐药性多发性骨髓瘤的CAR T细胞疗法.
- 以前的研究表明,ide-cel可以改善无进展生存期 (PFS) 和整体应答率 (ORR).
研究的目的:
- 在体内表征细胞扩张的ide-cell.
- 评估理想细胞细胞扩张和临床疗效和安全终点之间的关联.
- 评估对暴露-反应关系的共变量效应.
主要方法:
- 来自KarMMa-3研究的CAR转基因拷贝数的非分组分析.
- 暴露与反应关系的多变量回归分析.
- 与KarMMa研究中的数据进行比较.
主要成果:
- 在评估范围内的ide-cell剂量和细胞扩张之间没有强烈的关联.
- 在较高的细胞扩张和较长的PFS,较高的ORR和细胞因子释放综合征的增加率之间发现了积极的相关性.
- 在暴露-反应关系上没有发现临床相关的共变效应.
结论:
- 在体内,ide-cel的细胞扩张与临床疗效和安全性结果有关.
- 这些发现支持将ide-cell剂量范围扩展到300-510 × 10^6 CAR+ T细胞,用于三级暴露复发性/耐药性多发性髓瘤患者.
- 暴露-反应关系在KarmMa-3和KarmMa.Ma研究中是一致的.
更多相关视频
07:20Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
Published on: January 14, 2011
14.8K
06:25Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
Published on: March 29, 2024
1.0K
相关概念视频
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:49Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K